Literature DB >> 6139716

Cardiopulmonary bypass with a low-molecular-weight heparin fraction.

M Gouault-Heilmann, Y Huet, G Contant, D Payen, G Bloch, M Rapin.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6139716     DOI： 10.1016/s0140-6736(83)91142-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Specificity and selectivity profile of EP217609: a new neutralizable dual-action anticoagulant that targets thrombin and factor Xa.

Authors:  Steven T Olson; Richard Swanson; Maurice Petitou
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

Review 2.  Cardiopulmonary bypass in patients with pre-existing coagulopathy.

Authors:  William DeBois; Junli Liu; Leonard Lee; Leonard Girardi; Wilson Ko; Anthony Tortolani; Karl Krieger; O Wayne Isom
Journal:  J Extra Corpor Technol       Date:  2005-03

3.  Treatment of acute pulmonary embolism by a low molecular weight heparin fraction. A preliminary study.

Authors:  Y Huet; M Gouault-Heilmann; G Contant; C Brun-Buisson
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

Review 4.  Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.

Authors:  M Verstraete
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.